RARE vs RGNX Stock Comparison
Compare RARE and RGNX across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between RARE and RGNX?
RARE and RGNX are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.
AlgovestIQ AIQ Comparison
Ultragenyx Pharmaceutical Inc. vs REGENXBIO Inc.
RARE and RGNX are effectively level
RARE and RGNX are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.
Ultragenyx Pharmaceutical Inc.
REGENXBIO Inc.
The Algovestiq AIQ Score does not currently separate RARE and RGNX as of Sep 11, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.
Compare Ultragenyx Pharmaceutical Inc. and REGENXBIO Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare RARE and RGNX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience21 vs 55RGNX +34
- Quality64 vs 40RARE +24
- Value50 vs 56RGNX +6
- Momentum21 vs 25RGNX +4
Neither name separates cleanly on the covered dimensions.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
No factor moved materially.
New signals
- 52-Week Low Proximity — bearish, risk, long horizon (1.0%)
No factor moved materially.
No new signals fired.
Deeper signal detail for each name lives on its own signals page — RARE and RGNX both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EvenNeither separates on the overall score.
Growth
RGNXRGNX on combined revenue and EPS growth.
Value
RGNXRGNX on the peer-relative Value factor, by 6 points.
Momentum
RGNXRGNX on the Momentum factor, by 4 points.
Lower downside
RGNXRGNX on Risk Resilience, by 34 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | RARE | RGNX | Note |
|---|---|---|---|
| Implied upside to target | +154.9% | +154% | Level |
| Target dispersion | +183.8% | +92.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 12 | 5 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
How each independent group of evidence reads the pair.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 43 vs 43 |
| Fundamentals | RAREon balance | revenue growth 57.4% vs 15.9%; EPS growth 51.1% vs 125%; TTM ROE 3.9% vs -220.1%; gross margin 83.1% vs 54.2%; operating margin -73.8% vs -94.1% — RARE takes 4 of 5 decided legs, not all of them |
| Valuation | RGNX | Value 50 vs 56 |
| Technicals | RGNX | Price vs 50-day -46.4% vs -20.9%; vs 200-day -44% vs -16.8% |
| Risk Resilience | RGNX | Risk Resilience 21 vs 55 |
| Analyst expectations | Even | Target upside 154.9% vs 154% |
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 0 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
How the comparison changed
119 daily snapshots · May 4 – Sep 10RGNX lead: Stable — the AIQ differential has held near 0 points over 30 sessions.
- Today
- Level
- 43 vs 43
- 7 sessions ago
- RGNX +1
- 43 vs 44
- 30 sessions ago
- RGNX +1
- 49 vs 50
- 90 sessions ago
- RARE +8
- 58 vs 50
The lead changed hands 4 times in this window, most recently on Sep 3 when RGNX moved ahead of RARE.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 3 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (3.69%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
1 bullish / 1 bearish / 2 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (4.81%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (8.07%)
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.69%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.35%, AIQ 0 points).
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
RARE leads on balance| Metric | RARE | RGNX |
|---|---|---|
| Revenue growth (YoY) | 57.4% | 15.9% |
| EPS growth (YoY) | 51.1% | 125% |
| Gross margin | 83.1% | 54.2% |
| Operating margin | -73.8% | -94.1% |
| Return on equity (TTM) | 3.9% | -220.1% |
| Debt to equity | -4.13 | 0.96 |
Performance
RGNX leads 5 of 6 windows| Metric | RARE | RGNX |
|---|---|---|
| 1 week (5 sessions) | -41.1% | -10.8% |
| 1 month (20 sessions) | -43.4% | -21.5% |
| 3 months (63 sessions) | -37.3% | 39.6% |
| 6 months (126 sessions) | -35.2% | -8.7% |
| Year to date | -37.4% | -40.6% |
| 1 year (252 sessions) | -54.3% | -9.7% |
Technicals
RGNX has the stronger structure| Metric | RARE | RGNX |
|---|---|---|
| RSI (14) | 18.1 | 30.1 |
| ADX (14) | 27.2 | 15.3 |
| Price vs 50-day | -46.4% | -20.9% |
| Price vs 200-day | -44% | -16.8% |
| Volatility (1M, annualized) | 159.7% | 114.3% |
Risk
RGNX is the more resilient| Metric | RARE | RGNX |
|---|---|---|
| Beta | 1.19 | 1.98 |
| Sharpe ratio | -0.52 | 0.3 |
| Sortino ratio | -0.5 | 0.36 |
| Max drawdown | -60.8% | -64.6% |
| Current drawdown | -60.6% | -46.4% |
| Annualized volatility | 80.5% | 93.4% |
| Value at risk (95%) | -4.3% | -8.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which has more analyst upside, RARE or RGNX?
Analyst price targets imply +154.9% upside for RARE and +154% for RGNX. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, RARE or RGNX?
RGNX is the better-valued of the two on the peer-relative Value factor. RGNX on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, RARE or RGNX?
RGNX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, RARE or RGNX?
RGNX on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, RARE or RGNX?
RGNX is the more resilient of the two, so the other name carries the higher downside risk. RGNX on Risk Resilience, by 34 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is RARE more profitable than RGNX?
RARE leads on the comparable margin measures — gross margin 83.1% vs 54.2%; operating margin -73.8% vs -94.1%; ttm roe 3.9% vs -220.1%.
What do the current signals say about RARE and RGNX?
RARE: 2 bullish / 3 bearish / 1 neutral, conflicted. RGNX: 1 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RARE is Golden Cross Active (bullish, long horizon). On RGNX it is Golden Cross Active (bullish, long horizon).
Compare RARE and RGNX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.